Literature DB >> 15613857

Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas.

Bong K Kim1, Urvashi Surti, Amit Pandya, Jack Cohen, Michael S Rabkin, Steven H Swerdlow.   

Abstract

Although primary cutaneous follicular lymphoma (FL) is considered a distinct variant of FL in the World Health Organization classification ("cutaneous follicle center lymphoma"), its biologic relationship to nodal FL remains controversial. The clinical, morphologic, immunophenotypic, and molecular cytogenetic features of 17 patients with primary cutaneous FL were studied and compared with 16 patients with secondary cutaneous FL. The head and neck region was the most frequent site at initial skin presentation in both the primary and secondary cases. Among the primary cases, 29% of the 31 biopsies were grade 1, 48% grade 2, 13% grade 3, and 10% grade 3 with diffuse large B-cell (DLBCL) areas. Among the secondary cases, 38% of the 29 skin biopsies were grade 1, 45% grade 2, 3% grade 3, and 7% grade 3 with DLBCL areas with two not evaluable. A floral-like pattern was observed in 32% of primary FL but only 5% of secondary cases. Histologic progression was found in 21% of patients. CD10 expression was demonstrated in 90% (27 of 30) of primary cases and 96% (22 of 23) of secondary cases. Bcl-6 was expressed in all cases tested. Bcl-2 expression was detected in 57% (17 of 30) of the primary cases (100% of grade 1, 43% of grade 2, 40% of grade 3), whereas all secondary cases were bcl-2 positive (P=0.0002). The t(14;18) translocation was identified by interphase fluorescence in situ hybridization (FISH) in biopsies from 31% (4 of 13) of the patients with primary FL compared with 77% (10 of 13) of those with secondary lymphoma (P <0.05). Seven of the 17 (41%) patients with primary disease had cutaneous relapse, including 1 who also developed nodal disease. Bcl-2 positivity was seen in 4 of these 7 patients. Eight of the 16 (50%) patients with secondary FL had cutaneous relapse. Primary and secondary cutaneous FL share many clinical and phenotypic features, but primary cases may have some distinctive morphologic features, more frequently lack bcl-2 protein, and often lack the t(14;18) translocation. These findings suggest that primary cutaneous FL are distinctive and often but not always have a pathogenesis different from most of nodal and secondary cutaneous FL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15613857     DOI: 10.1097/01.pas.0000146015.22624.c7

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  20 in total

1.  [Malignant lymphoma of the skin: update on diagnostics and therapy of primary cutaneous B-cell lymphoma].

Authors:  C Hallermann; C Niermann; M Fluck; A-R Fischedick; H-J Schulze
Journal:  Hautarzt       Date:  2011-12       Impact factor: 0.751

Review 2.  Lymphoproliferative lesions of the skin.

Authors:  L Cerroni
Journal:  J Clin Pathol       Date:  2006-08       Impact factor: 3.411

3.  Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.

Authors:  Ambrus Gángó; Bence Bátai; Martin Varga; Dóra Kapczár; Gergő Papp; Márta Marschalkó; Enikő Kuroli; Tamás Schneider; Judit Csomor; András Matolcsy; Csaba Bödör; Ágota Szepesi
Journal:  Virchows Arch       Date:  2018-06-01       Impact factor: 4.064

Review 4.  Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.

Authors:  Scott D Boyd; Yasodha Natkunam; John R Allen; Roger A Warnke
Journal:  Appl Immunohistochem Mol Morphol       Date:  2013-03

Review 5.  Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Authors:  Karthik A Ganapathi; Stefania Pittaluga; Oreofe O Odejide; Arnold S Freedman; Elaine S Jaffe
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

6.  ''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases.

Authors:  Olga K Weinberg; Weiyun Z Ai; M Rajan Mariappan; Carol Shum; Ronald Levy; Daniel A Arber
Journal:  J Mol Diagn       Date:  2007-07-25       Impact factor: 5.568

7.  Follicular lymphoma of the thyroid gland.

Authors:  Chris M Bacon; Timothy C Diss; Hongtao Ye; Hongxiang Liu; Alison Goatly; Rifat Hamoudi; Andrew Wotherspoon; Randy D Gascoyne; Ahmet Dogan; Ming-Qing Du; Peter G Isaacson
Journal:  Am J Surg Pathol       Date:  2009-01       Impact factor: 6.394

8.  Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.

Authors:  Olga K Weinberg; Lisa Ma; Katie Seo; Andrew H Beck; Reetesh K Pai; Anjali Morales; Youn Kim; Uma Sundram; Daryl Tan; Sandra J Horning; Richard T Hoppe; Yasodha Natkunam; Daniel A Arber
Journal:  Am J Surg Pathol       Date:  2009-04       Impact factor: 6.394

9.  Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.

Authors:  Xiaolong Alan Zhou; Jingyi Yang; Kimberly G Ringbloom; Maria Estela Martinez-Escala; Kristen E Stevenson; Alexander T Wenzel; Damiano Fantini; Haley K Martin; Andrea P Moy; Elizabeth A Morgan; Shannon Harkins; Christian N Paxton; Bo Hong; Erica F Andersen; Joan Guitart; David M Weinstock; Lorenzo Cerroni; Jaehyuk Choi; Abner Louissaint
Journal:  Blood Adv       Date:  2021-02-09

10.  The role of molecular pathology in the diagnosis of cutaneous lymphomas.

Authors:  Philipp W Raess; Adam Bagg
Journal:  Patholog Res Int       Date:  2012-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.